CatalYmtoday announced that the first patient has been dosed in the randomized Phase 2b GDFATHER‑NSCLC‑02 (GDF‑15 Antibody‑MediaTed‑Human‑Effector‑T‑Cell Relocation) trial (NCT07246863). The trial ...

Circle Line users face longer waits of up to 30 minutes from Jan 17-April 19, 2026, due to tunnel reinforcement between Mountbatten, Dakota and Paya Lebar. Shuttle trains will operate on the affected ...

Sai Parenteral's Ltd, a drug formulation company which has filed its draft papers with the capital markets regulator for an initial public offering, has acquired an Australian pharmaceutical company.

Natural Gas prices have risen back well as expected after a short-lived correction. The Natural Gas futures contract on the Multi Commodity Exchange (MCX) fell to a low of ₹375.60 per mmBtu last week ...

The Circle tube line was suspended completely for hours on Monday morning when a person died on the tracks at Gloucester Road. Transport for London (TfL) had the line has now reopened and is operating ...

(CNN) — The Trump administration has another idea to make housing more affordable: Let homeowners take their mortgage rate with them when they move. On Wednesday, Federal Housing Finance Agency ...

The stock's Price to Earnings ratio of 33.97 is lower than the industry average by 0.85x, suggesting potential value in the eyes of market participants. It could be trading at a premium in relation to ...

A passenger went missing from a Norwegian Cruise Line ship that was heading to Miami, company officials confirmed. The guest reportedly went overboard Monday while the Norwegian Jewel ship was sailing ...

Warner Bros. Discovery is reviewing “strategic alternatives” in light of “unsolicited interest” it has received from multiple parties for both the entire company and the standalone Warner Bros.

Seatrium shares drop 6.5% after contract cancellation Maersk cites construction delays Seatrium considers legal action over contract termination Trump administration previously halted Empire Wind ...

A leading European medical group announced a new framework for treating obesity on Thursday, recommending Novo’s (NVO) semaglutide and Lilly’s (NYSE:LLY) tirzepatide, marketed as Wegovy and Zepbound, ...